[Troponin elevation in the absence of acute coronary syndrome]

Area of Science:

• Cardiology
• Biomarkers
• Clinical Diagnostics

Background:

• Cardiac troponins are highly sensitive and specific biomarkers for myocardial injury.
• Elevated cardiac troponin levels are observed in various conditions, not exclusively thrombotic acute coronary syndromes.
• Interpreting dynamic changes in troponin levels can be complex in clinical practice.

Purpose of the Study:

• To clarify the interpretation of cardiac troponin levels in diverse clinical scenarios.
• To emphasize the importance of integrating troponin data with clinical presentation and other diagnostic findings.
• To define the prognostic and risk stratification value of troponin beyond acute coronary syndromes.

Main Methods:

• Review of clinical guidelines and diagnostic criteria for cardiac troponin testing.
• Analysis of troponin kinetics and its correlation with clinical outcomes.
• Case study examples illustrating the interpretation of troponin in non-ACS conditions.

Main Results:

• Cardiac troponin elevation alone does not confirm a thrombotic acute coronary syndrome.
• Troponin evaluation necessitates a comprehensive assessment including clinical context, ECG, and troponin kinetics.
• In the absence of thrombotic ACS, troponin levels retain prognostic significance.

Conclusions:

• Troponin testing should be guided by clinical indication and interpreted holistically.
• Understanding troponin dynamics is crucial for accurate diagnosis and risk assessment.
• Cardiac troponin has prognostic value in conditions such as pulmonary embolism, pericarditis, and myocarditis, beyond its role in ACS.